LEGN
Legend Biotech Corp
NASDAQ: LEGN · HEALTHCARE · BIOTECHNOLOGY
$22.77
-3.35% today
Updated 2026-04-29
Market cap
$4.21B
P/E ratio
—
P/S ratio
4.09x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $45
Volume
1.9M
Legend Biotech Corp (LEGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.38M | $307.68M | $-83.06M | $-223.00M | $-198.47M | $-201.28M | $-393.28M | $-144.03M | $-100.47M |
| Capital expenditures | $887000.00 | $21.02M | $39.17M | $30.28M | $45.40M | $22.27M | $22.72M | $14.11M | $67.58M |
| Depreciation | $217000.00 | $1.68M | $5.26M | $9.93M | $13.92M | $18.39M | $20.45M | $23.36M | — |
| Stock-based comp | — | $704000.00 | $1.27M | $4.76M | $20.16M | $34.34M | $47.68M | $68.94M | $64.60M |
| Free cash flow | $-3.26M | $286.66M | $-122.23M | $-253.29M | $-243.87M | $-223.56M | $-416.00M | $-158.14M | $-168.04M |
| Investing cash flow | $-827000.00 | $-102.26M | $-58.65M | $-24.17M | $-194.98M | $-77.09M | $92.79M | $-850.54M | — |
| Financing cash flow | $3.32M | $2.50M | $14.67M | $618.88M | $626.66M | $377.98M | $791.49M | $5.70M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |